![Health / Chugai Pharmaceutical Co. / Ibandronic acid / Anatomy / Taisho Pharmaceutical Co. / Bone density / Medicine / Bisphosphonates / Osteopathies / Osteoporosis Health / Chugai Pharmaceutical Co. / Ibandronic acid / Anatomy / Taisho Pharmaceutical Co. / Bone density / Medicine / Bisphosphonates / Osteopathies / Osteoporosis](https://www.pdfsearch.io/img/589156d736dcca45a635fe38f7ee178e.jpg)
| Document Date: 2015-02-10 01:01:03 Open Document File Size: 16,35 KBShare Result on Facebook
City Tokyo / Basel / / Company Chugai Pharmaceutical Co. Ltd. / Taisho Pharmaceutical Co. Ltd. / Translation Taisho Pharmaceutical Co. Ltd. / Taisho Toyama Pharmaceutical Co. Ltd. / F. Hoffmann-La Roche Ltd. / / Country Switzerland / Japan / United States / / Event FDA Phase / / IndustryTerm osteoporosis treatment / healthcare professionals / prevention of osteoporosis / treatment of osteoporosis / / MedicalCondition osteoporosis / / Organization Ministry of Health / / Person Akira Ohira / Osamu Nagayama / Shigeru Uehara / / Position CEO / President / Head Office / Chairman & CEO / / Product Boniva / RG484 oral / Bonviva® IV Injection / Bisphosphonate Antiresorptive Agent / Ibandronate Sodium Hydrate Oral Agent / /
SocialTag |